PI
Cancer Center Amsterdam
-
Monoclonal Antibodies in the Treatment of Multiple Myeloma
van de Donk, N. W. C. J. & Zweegman, S., Apr 2024, In: Hematology/oncology clinics of North America. 38, 2, p. 337-360 24 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
Frerichs, K. A., Verkleij, C. P. M., Mateos, M. V., Martin, T. G., Rodriguez, C., Nooka, A., Banerjee, A., Chastain, K., Perales-Puchalt, A., Stephenson, T., Uhlar, C., Kobos, R., van der Holt, B., Kruyswijk, S., Kuipers, M. T., Groen, K., Vishwamitra, D., Skerget, S., Cortes-Selva, D., Doyle, M., & 4 others , 9 Jan 2024, In: Blood. 8, 1, p. 194-206 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Mian, H., McCurdy, A., Giri, S., Grant, S., Rochwerg, B., Winks, E., Rosko, A. E., Engelhardt, M., Pawlyn, C., Cook, G., Jackson, G., Bringhen, S., Facon, T., Larocca, A., Zweegman, S. & Wildes, T. M., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 6.Research output: Contribution to journal › Article › Academic › peer-review
- All publications